Available Online: Biodefense and Infectious Diseases Funding Opportunities Webinar

The National Institute of Allergies and Infectious Diseases (NIAID) awards close to $6,000,000,000 annually. Taking into account activities by DTRA, DARPA, US Army, BARDA, etc., this is a funding force no one in the field can afford to ignore.

In this webinar, we introduce you to Biodefense and Infectious Diseases sources of funding such as NIAID, DTRA, DARPA, US Army, and BARDA, and give examples of current open solicitations. We discuss the process for applying, major challenges, and how to maximize your chances for award.

 

View Slide Deck

/0 Comments/by
You might also like
Dr. Mike Minnicozzi will speak at the 18th Annual Non-Dilutive Funding Summit, in San Franciso, at the Marines' Memorial Club and Hotel Union Square, on January 11, 2023. He is a senior Program Officer for the National Institute of Allergy and Infectious Diseases (NIAID), NIH. In his current position, Mike works in the Division of Allergy, Immunology and Transplantation (DAIT) where he administers and oversees a research portfolio of grants, cooperative awards and contracts, on topics such as Allergy, Asthma, Atopic Dermatitis and Sepsis.NIAID to Speak at the Non-Dilutive Funding Summit 2023
$7.245 Billion in Funding Opportunities for Cancer Research. Join our webinar to fund out more.Cancer Research in 2022: More than $7 Billion in Funding Opportunities
Available Online: Non-Dilutive Funding Opportunities for Pre-Clinical Reseach Webinar
AN INTRO TO SBIR
Dr. Natalia Kruchinin is SBIR/STTR Program Coordinator and Director at the National Institute of Allergy and Infectious Disease (NIAID) of the National Institutes of Health. Come hear her speak via livestream, at the 18th Annual Non-Dilutive Funding Summit, Wednesday, January 11, 2023, at the Marines' Memorial Club and Hotel, Union Square, San FranciscoNIAID to Present at NDFS 2023
Available Online: Non-Dilutive Funding for Non-US Applicants
Peer-Reviewed Alzheimer’s Research Program
NDFS13 NIH Presentation: Overview and Update on HHS SBIR/STTR Programs
0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published. Required fields are marked *